Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-31 @ 11:47 PM
Study NCT ID:
NCT05395533
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-25
First Post:
2022-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
Sponsor:
Zhejiang Teruisi Pharmaceutical Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-19
First Submit QC Date:
None
Study First Post Date:
2022-05-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-18
Last Update Post Date:
2025-06-25
Last Update Post Date Type:
ACTUAL